RE: Another4 Dec 2018 15:28
We must be due news on the Bio Pharma process.
Changes since this time last year:
1) Major Disti deals in Europe, Far East and US
2) Bio Pharma progressing as per Phase 2 with the partner adding more resources to this phase
3) Launch of new Product 4500 MiD(R)
4) Good progress with outsourcing Microsaic's remaining in-house micro-fabrication manufacturing to its assembly partner, based in the UK.
5) Balance sheet strengthened as a result of fundraising
6) Unicorn increase in holding to over 16%
These are just to name a few.